Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Function Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06692322
What this trial is testing

Test How Zongertinib is Taken up in the Blood of People With and Without Liver Problems

Who this might be right for
Liver DiseasesHealthy
Boehringer Ingelheim 29
Not applicableNot Yet RecruitingNCT07056270
What this trial is testing

Development of a Set of Auxiliary Decision-making System for the Perioperative Period of Hepatectomy Based on Static CT and Artificial Intelligence.

Who this might be right for
Liver CirrhosisLiver Cancer
Tongji Hospital 500
Not applicableStudy completedNCT03601845
What this trial is testing

MRE-IA in Liver Disease and Neurovascular Imaging

Who this might be right for
Diffuse and Focal Liver Diseases, Cerebral Function
Université de Sherbrooke 59
Testing effectiveness (Phase 2)Study completedNCT02115373
What this trial is testing

C-Met Second-Line Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Merck KGaA, Darmstadt, Germany 66
Early research (Phase 1)Study completedNCT00969813
What this trial is testing

A Safety and Tolerability Study of CP-690,550 in Subjects With Hepatic Impairment and Normal Hepatic Function

Who this might be right for
Hepatic Insufficiency
Pfizer 18
Early research (Phase 1)Study completedNCT02894385
What this trial is testing

Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)

Who this might be right for
PharmacokineticsHepatic InsufficiencyRenal Insufficiency
Bayer 29
Not applicableStudy completedNCT00825617
What this trial is testing

Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy

Who this might be right for
Turner Syndrome
University of Aarhus 16
Large-scale testing (Phase 3)UnknownNCT03578055
What this trial is testing

BDD With UDCA Therapy After Laparoscopic Cholecystectomy

Who this might be right for
Cholecystitis, AcuteCholecystitis, Chronic
Ewha Womans University Mokdong Hospital 172
Early research (Phase 1)Study completedNCT05283915
What this trial is testing

Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hepatic Impairment Compared to Participants With Normal Hepatic Function

Who this might be right for
Hepatic Function Abnormal
Sanofi 10
Not applicableStudy completedNCT04698148
What this trial is testing

Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gastrointestinal Diseases

Who this might be right for
Clostridium Difficile InfectionMulti Drug Resistant OrganismsChronic Inflammatory Bowel Disease+2 more
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 225
Not applicableLooking for participantsNCT05977283
What this trial is testing

HBsAg Declined Patients Follow-up Study

Who this might be right for
Hepatitis BHepatitis B, Chronic
Nanfang Hospital, Southern Medical University 100
Not applicableStudy completedNCT03386435
What this trial is testing

The Effect of Remote Ischemic Preconditioning in Living Donor Hepatectomy

Who this might be right for
Tissue DonorsLiver TransplantationIschemia Reperfusion Injury
Asan Medical Center 160
Very early researchStudy completedNCT02789150
What this trial is testing

Outcomes of Renal Function in Hepatorenal Syndrome (HRS) Determined By Comparison of Target Mean Arterial Pressure (MAP) of 65 - 70 Mmhg Versus ≥ 85 Mmhg

Who this might be right for
Hepatorenal Syndrome
University of Louisville 18
Post-approval studies (Phase 4)Study completedNCT01588418
What this trial is testing

Acute Effect of Exenatide on Brain Glucose Metabolism

Who this might be right for
Impaired Glucose Tolerance (IGT)Diabetes
The University of Texas Health Science Center at San Antonio 15
Not applicableUnknownNCT00709085
What this trial is testing

To Study the Effects of Host Genetic Factors on Liver Cirrhosis and Hepatocellular Carcinoma (HCC)

Who this might be right for
Liver Cirrhosis
National Taiwan University Hospital 320
Not applicableStudy completedNCT03140917
What this trial is testing

Multimodal Assessment of Liver Volume and Function

Who this might be right for
Colorectal CancerLiver Metastases
Karolinska University Hospital 10
Testing effectiveness (Phase 2)Study completedNCT04522908
What this trial is testing

Dose Escalation Study of Cabozantinib for Advanced HCC Patients With Preserved Liver Function

Who this might be right for
Hepatocellular Carcinoma (HCC)Second Line Treatment
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 40
Early research (Phase 1)Study completedNCT07625618
What this trial is testing

A Pharmacokinetic and Safety Study of MY008211A Tablets in Subjects With Impaired or Normal Hepatic Function

Who this might be right for
Hepatic Insufficiency (MeSH ID: D048550)
Wuhan Createrna Science and Technology Co., Ltd 24
Not applicableNot Yet RecruitingNCT06749340
What this trial is testing

Examining the Effects of Different Resistive Exercise Programs in Individuals With Compensated Liver Cirrhosis

Who this might be right for
Coginitive DysfunctionCompensated Liver CirrhosisPhysical Dysfunction+1 more
Bahçeşehir University 20
Early research (Phase 1)WithdrawnNCT03912350
What this trial is testing

The Effect of Hepatic Impairment on the Pharmacokinetics of Balovaptan

Who this might be right for
Autism Spectrum Disorder
Hoffmann-La Roche
Next Page